MB-CART19.1 Clinical Trials
3 recruitingBiologic
Not Applicable2Phase 11Phase 21
Showing 1–3 of 3 trials
Recruiting
Not Applicable
MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia RefractoryAcute Lymphoblastic Leukemia With Failed Remission+2 more
King Hussein Cancer Center12 enrolled1 locationNCT07371403
Recruiting
Not Applicable
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
Melanoma Stage IVPediatric ALLMelanoma Stage III+4 more
Miltenyi Biomedicine GmbH40 enrolled7 locationsNCT06508775
Recruiting
Phase 1Phase 2
MB-CART19.1 in Refractory SLE
SLE - Systemic Lupus Erythematosus
Miltenyi Biomedicine GmbH29 enrolled3 locationsNCT06189157